PORCILIS® BEGONIA Per dose: At least 105.5 TCID50 of Aujeszky’s disease virus strain Begonia. This strain neither synthesizes thymidine kinase (tk-) nor the glycoprotein 1 (gE-).

P.G.600® Induces heat in prepuberal gilts and weaned sows experiencing delayed return to estrus. 89% of sows treated with P.G. 600 exhibit signs of estrus within four to five days of weaning. Reduction of non-productive days reduces feed costs and improves pig flow, which leads to improved productivit.

PORCILIS® PARVO an inactivated vaccine against parvovirus infection for use in pigs. Porcilis Parvo is an inactivated vaccine containing Porcine parvovirus (PPV) strain 014 ≥ 552 EU per dose (as determined in the final product antigenic mass ELISA) in an aqueous adjuvant. The vaccine contains 0.02% formaldehyde as a preservative and 150 mg dl-α tocopherol per dose.

PORCILIS® AR-T-DF is a vaccine for use in pigs to reduce atrophic rhinitis in their piglets. Porcilis AR-T DF is a suspension for injection which contains a non-toxic recombinant derivative of the Pasteurella multocida toxin and inactivated Bordetella bronchiseptica cells.